IceCure Medical GAAP EPS of $0.12, revenue of $1.25M

* IceCure Medical press release [https://seekingalpha.com/pr/20199429-icecure-reports-financial-and-operational-results-for-the-first-half-of-2025] (NASDAQ:ICCM [https://seekingalpha.com/symbol/ICCM]): 1H GAAP EPS of $0.12.
* Revenue of $1.25M.
*
As of June 30, 2025, the Company had cash and cash equivalents, including short-term deposits, of approximately $5.38 million, including a $2 million bridge loan from its major shareholder. During the first half of 2025, the Company raised $2.65 million in net proceeds from the sale of 2,127,961 ordinary shares under its at-the-market offering facility.

*

MORE ON ICECURE MEDICAL

* IceCure Medical Ltd (ICCM) Q1 2025 Earnings Call Transcript [https://seekingalpha.com/article/4790626-icecure-medical-ltd-iccm-q1-2025-earnings-call-transcript]
* IceCure Medical GAAP EPS of -$0.06 beats by $0.01, revenue of $0.73M misses by $0.25M [https://seekingalpha.com/news/4453556-icecure-medical-gaap-eps-of-0_06-beats-by-0_01-revenue-of-0_73m-misses-by-0_25m]
* IceCure Medical outlines post-market study plan for ProSense amid FDA engagement and prepares for US commercial launch [https://seekingalpha.com/news/4453185-icecure-medical-outlines-post-market-study-plan-for-prosense-amid-fda-engagement-and-prepares]
* Seeking Alpha’s Quant Rating on IceCure Medical [https://seekingalpha.com/symbol/ICCM/ratings/quant-ratings]
* Historical earnings data for IceCure Medical [https://seekingalpha.com/symbol/ICCM/earnings]